Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effect of live attenuated varicella vaccine on development of herpes zoster
jRCTs061190019Recruiting
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Dec 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of varicella vaccine live in herpes zoster (HZ), sponsored by Research Foundation for Microbial Diseases of Osaka University. Primary endpoint: Development of herpes zoster. Started Dec 2019; status: recruiting.
02
Drugs
varicella vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on jRCTs061190019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061190019.